Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 7—July 2015

Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam

Cite This Article

In Response: We agree with Ringwald and Dondorp (1) that our report of a Vietnamese worker returning from Angola with severe Plasmodium falciparum malaria not responsive to artemisinins (2) is unlikely to indicate that artemisinin resistance has reached Angola. Nevertheless, this case, for its unusual clinical manifestation and response to treatment, had raised alarm in Vietnam, where the number of imported malaria cases and deaths among Vietnamese workers returning from Africa has recently increased (3,4). After our report was published in July 2014, we collected additional information that may be useful in putting such a case in perspective.

The results of an external quality control study by Sigma-Tau Pharmaceuticals on 10 vials of the same batch (no. 511002) of intravenous artesunate as administered to our case-patient (report available on request) confirmed acceptable drug concentration and showed that the opalescence observed after reconstitution was caused by precipitation of an impurity (representing 0.12% of the preparation) identified as an active metabolite of artesunate. Therefore, the treatment administered to the patient was of acceptable quality. The blood concentrations of artesunate and dihydroartemisinin may have been 20% lower than ideal (as predicted by a pharmacokinetic model), but this finding cannot explain why the parasite density remained >200,000/μL for several days.

Ringwald and Dondorp also mention functional asplenia as a possible cause of delayed parasite clearance. We argue that this would have resulted in a much longer (weeks/months) parasite clearance (5) than the observed sharp decrease after quinine and tetracycline administration. Moreover, we did not observe any accumulation of circulating dead parasites (Howell-Jolly bodies), which is against the hypothesis of functional asplenia. Furthermore, sharp decline of parasite density immediately after quinine and doxycycline administration by nasogastric tube is not consistent with the proposed hypothesis of reduced intestinal absorption.

In hindsight and after consideration of additional information, we agree that it is unlikely this patient harbored several resistant parasite clones. However, the reasons for the lack of response to arteminins in this patient remain unknown and are under continued investigation.

The discussion triggered by the publication of our case report raises the question of what should be reported to the attention of the scientific community and public health authorities. Besides being an obligation for clinical physicians, reporting unusual treatment failures such as our case is also an essential component of antimalarial resistance surveillance. As mentioned by Ringwald and Dondorp, “vigilant monitoring is pivotal” for the detection of possible foci of resistance. For early detection of artemisinin resistance, we would rather have a more sensitive than specific system, because the latter would probably miss the first emerging cases of resistance. Reporting cases similar to the one we published should be encouraged.


Nguyen Van Hong, Alfred Amambua-Ngwa, Nguyen Quang Tuan, Do Duy Cuong, Nguyen Thi Huong Giang, Nguyen Van Dung, Ta Thi Tinh, Nguyen Van Tien, Bui Quang Phuc, Tran Thanh Duong, Anna Rosanas-Urgell, Jean-Pierre Van Geertruyden, Umberto D’Alessandro, and Annette ErhartComments to Author 
Author affiliations: National Institute of Malariology, Parasitology and Entomology, Hanoi, Vietnam (N. Van Hong, T.T. Tinh, B.Q. Phuc, T.T. Duong); Medical Research Unit, Fajara, The Gambia (A. Amambua-Ngwa, U. D’Alessandro); Bach Mai Hospital, Hanoi (N.Q. Tuan, D.D. Cuong, N.T.H. Giang, N. Van Dung, N. Van Tien); Institute of Tropical Medicine, Antwerp, Belgium (A. Rosanas-Urgell, A. Erhart); University of Antwerp (J.-P. Van Geertruyden)



  1. Ringwald  P, Dondorp  AM. Severe malaria not responsive to artemisinin derivatives in man returning from Angola to Vietnam. Emerg Infect Dis. 2015;21:126465. DOIGoogle Scholar
  2. Van Hong  N, Amambua-Ngwa  A, Tuan  NQ. Cuong do D, Giang NT, Van Dung N, et al. Severe malaria not responsive to artemisinin derivatives in man returning from Angola to Vietnam. Emerg Infect Dis. 2014;20:1199–202.PubMedGoogle Scholar
  3. National Institute of Malariology, Parasitology and Entomology (NIMPE). Annual report of the National Malaria Control Program in Vietnam of 11 months in 2013. Hanoi (Vietnam): The Institute; 2013.
  4. National Institute of Malariology, Parasitology and Entomology (NIMPE). Annual report of the National Malaria Control Program in Vietnam: 2014. Hanoi (Vietnam): The Institute; 2015.
  5. Chotivanich  K, Udomsangpetch  R, McGready  R, Proux  S, Newton  P, Pukrittayakamee  S, Central role of the spleen in malaria parasite clearance. J Infect Dis. 2002;185:153841. DOIPubMedGoogle Scholar


Cite This Article

DOI: 10.3201/eid2107.150402

Related Links


Table of Contents – Volume 21, Number 7—July 2015

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Annette Erhart, Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerp, Belgium

Send To

10000 character(s) remaining.


Page created: June 16, 2015
Page updated: June 16, 2015
Page reviewed: June 16, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.